<h1>Krebs Biochemicals Announces Board Meeting to Adopt Q1 Unaudited Financial Results</h1>
Krebs Biochemicals & Industries Limited has scheduled its Board of Directors meeting to review and adopt the unaudited financial results for the first quarter ended June 30, 2026. The board meeting is set to take place on Thursday, August 6, 2026.
The meeting is intended to cover among other matters the considerations and adoption of the company's Q1 results.
In addition to the Board meeting announcement, the company reiterated the status regarding the trading window for its securities by insiders. As communicated previously, the insider trading window remains closed from the closure of business hours on June 30, 2026. The restriction will remain in place until 48 hours following the declaration of the unaudited financial results for the first quarter ending June 30, 2026.
KREBSBIO Stock Price Movement
Krebs Biochemicals and Industries Limited is slipping as of 10:58 AM, with shares shedding 1.08% in live trading, presently valued at ₹54.90. The stock has seen significant intraday movement, having traded within a range anchored by a low of ₹53.80 and a high of ₹55.00 today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.